What are the blood pressure targets and management recommendations for arterial hypertension in adults, including elderly patients?

Blood Pressure Targets and Management for Arterial Hypertension

Target a blood pressure of <130/80 mmHg for most adults with hypertension, including those aged 65-80 years, and individualize to <140/90 mmHg only for patients ≥85 years or those with clinically significant frailty. This recommendation is based on the most recent 2024 ESC and 2025 AHA/ACC guidelines, which demonstrate that lower BP targets reduce stroke and cardiovascular events without increasing adverse effects 1, 2.

Blood Pressure Targets by Patient Population

General Adult Population (Age <65 years)

• Primary target: 120-129/70-79 mmHg if treatment is well tolerated 2
• Minimum threshold to initiate treatment:
  • High-risk patients (CVD, CKD, diabetes, organ damage): Start at ≥130/80 mmHg 1
  • Low-moderate risk patients: Start at ≥140/90 mmHg after 3-6 months of lifestyle intervention 3

Older Adults (Age 65-84 years)

• Target: <130/80 mmHg if well tolerated 3, 1, 2
• This target is supported by high-certainty evidence showing reduced stroke (RR 1.33,95% CI 1.06-1.67) and cardiovascular events (RR 1.25,95% CI 1.09-1.45) compared to targets of <150/90 mmHg 4
• Real-world data from 132,430 patients confirms lower BP targets (<130/80 mmHg) reduce CVD and mortality in those aged 60-79 without increasing adverse events 5

Very Elderly (Age ≥85 years) and Frail Patients

• Target: As low as reasonably achievable (ALARA principle), preferably <140/90 mmHg 2
• For patients with moderate-to-severe frailty, symptomatic orthostatic hypotension, or limited life expectancy (<3 years), accept systolic BP in the 130-140 mmHg range if lower targets cause symptoms 2
• Critical caveat: Monotherapy may be appropriate for patients >80 years or those who are frail 3

Diagnostic Thresholds

Office Blood Pressure Measurement

• Hypertension diagnosis: Office BP ≥140/90 mmHg confirmed over 2-3 visits 3
• Measure BP in both arms simultaneously at first visit; use the arm with higher readings 3
• Use validated automated upper arm cuff device with appropriate cuff size 3

Confirmatory Testing

• Home BP: ≥135/85 mmHg confirms hypertension 3
• 24-hour ambulatory BP: ≥130/80 mmHg confirms hypertension 3

Treatment Initiation Strategy

Grade 1 Hypertension (140-159/90-99 mmHg)

1. Start immediately in high-risk patients: CVD, CKD, diabetes, organ damage, or age 50-80 years 3
2. Start after 3-6 months of lifestyle intervention in low-moderate risk patients with persistent elevation 3

Grade 2 Hypertension (≥160/100 mmHg)

• Start drug treatment immediately alongside lifestyle interventions 3

Pharmacological Management Algorithm

Non-Black Patients

Step 1: Low-dose ACEI or ARB
Step 2: Add DHP-CCB
Step 3: Increase to full doses
Step 4: Add thiazide/thiazide-like diuretic
Step 5: Add spironolactone (or if contraindicated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker) 3

Black Patients

Step 1: Low-dose ARB + DHP-CCB (or DHP-CCB + thiazide/thiazide-like diuretic)
Step 2: Increase to full doses
Step 3: Add diuretic or ACEI/ARB
Step 4: Add spironolactone (or alternatives as above) 3, 6

Key Medication Principles

• Prefer single-pill combinations to improve adherence 6
• Use once-daily dosing when possible 3
• Never combine ACEI + ARB simultaneously 6
• Consider monotherapy only for low-risk Grade 1 hypertension and patients >80 years or frail 3

Monitoring and Follow-Up

Timeline to Achieve Target

• Achieve BP control within 3 months of treatment initiation 3
• Follow-up at 1 month after starting therapy, then every 3-6 months once at goal 6

Minimum BP Reduction Goal

• Reduce BP by at least 20/10 mmHg from baseline, even if target not fully achieved 3

Critical Pitfalls to Avoid

1. Do not undertreated based solely on age: The 2024 ESC guidelines explicitly reject systolic BP targets of 135 mmHg as suboptimal 2. Evidence shows older adults benefit from intensive BP lowering without increased adverse events 4, 5.

2. Monitor for orthostatic hypotension: Particularly in elderly patients, measure BP standing after 1-3 minutes 2

3. Assess frailty systematically: Use comprehensive geriatric assessment to guide intensity of treatment in those ≥85 years 2

4. Check medication adherence before escalating therapy 3

5. Refer to hypertension specialist if BP remains uncontrolled despite 4-drug regimen 3

Evidence Reconciliation

The 2022 ACC/AHA harmonization document 6 and 2024 ESC guidelines 2 converge on lower BP targets compared to older recommendations. While the 2020 ISH guidelines 3 suggest <140/90 mmHg as acceptable, the most recent 2024-2025 guidelines 1, 2 provide stronger evidence for <130/80 mmHg targets. The Cochrane review 4 confirms that lower targets reduce stroke and cardiovascular events in older adults without increasing withdrawals due to adverse effects, supporting the more aggressive approach in the latest guidelines.